☆ 4.7 Editorial Material

Progress in the Early Detection of Risk of End-Stage Kidney Disease in Diabetes at Last?

CLINICAL CHEMISTRY (2023)

National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories

W. Greg Miller et al.

Summary: Recognizing that race is a social construct, there is a push to remove race from clinical algorithms for diagnosing kidney diseases. The Task Force recommends using the newly published CKD-EPI 2021 equation for eGFR calculations without a race coefficient.

CLINICAL CHEMISTRY (2022)

添加到收藏夹

Article Cell Biology

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes

Hiroki Kobayashi et al.

Summary: The concentration of circulating neuroblastoma suppressor of tumorigenicity 1 (NBL1) is closely associated with the risk of progression to end-stage kidney disease (ESKD) in diabetic kidney disease (DKD), and it participates in the pathogenesis of DKD by inducing apoptosis in podocytes.

SCIENCE TRANSLATIONAL MEDICINE (2022)

添加到收藏夹

Article Urology & Nephrology

Measured and estimated glomerular filtration rate: current status and future directions

Andrew S. Levey et al.

NATURE REVIEWS NEPHROLOGY (2020)

添加到收藏夹

Review Urology & Nephrology

TGF-β: the master regulator of fibrosis

Xiao-ming Meng et al.

NATURE REVIEWS NEPHROLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

Paul E. Stevens et al.

ANNALS OF INTERNAL MEDICINE (2013)

添加到收藏夹

Progress in the Early Detection of Risk of End-Stage Kidney Disease in Diabetes at Last?

相关参考文献

National Kidney Foundation Laboratory Engagement Working Group Recommendations for Implementing the CKD-EPI 2021 Race-Free Equations for Estimated Glomerular Filtration Rate: Practical Guidance for Clinical Laboratories

Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes

Measured and estimated glomerular filtration rate: current status and future directions

TGF-β: the master regulator of fibrosis

Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline

导出引文

分享论文